FLINT, Mich., July 28, 2014 /PRNewswire/ -- Diplomat, the nation's largest independent specialty pharmacy, announced today that it has been selected as a provider of Zydelig(®) tablets. Zydelig was approved by the U.S. Food and Drug Administration on July 23, 2014 for the treatment of three B-cell blood cancers.
"We are pleased to partner with Gilead and be included in the limited panel of distribution for Zydelig," said Gary Kadlec, R.Ph, President of Diplomat. "Our expertise in working with limited-distribution drugs along with our comprehensive patient care programs provides the support needed to improve patient compliance, adherence and outcomes."
Zydelig(®) is indicated for the treatment of relapsed follicular B-Cell non-Hodgkin lymphoma (FL), small lymphocytic lymphoma, and in combination with rituximab for patients with relapsed chronic lymphocytic leukemia (CLL). Over 200,000 patients in the U.S. are living with FL, SLL or CLL which are slow-growing incurable blood cancers that can lead to life-threatening complications such as anemia, serious infection and bone marrow failure. Full prescribing information is available at www.gilead.com
Diplomat's high-touch approach to patient care achieved a 99% patient satisfaction rating in 2013. The specialty pharmacy's care programs include timely prescription delivery, side-effect management support and 24 hour access to patient care coordinators, nurses and pharmacists.
Zydelig(®) is available to dispense immediately.
To learn more, visit diplomat.is.
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.
Diplomat serves patients and physicians in all 50 states as the nation's largest independent specialty pharmacy. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with specialized, long-term medical needs, including oncology, immunology, hepatitis, multiple sclerosis, HIV, infusion therapy and many other serious or chronic conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients, and the rest falls into place." Today, that tradition continues - always focused on increasing adherence and improving outcomes. Diplomat has accreditations from URAC, VAWD, ASHP and ACHC. Learn more at diplomat.is.
Gary Rice, R.Ph., Diplomat
810.768.9863 | GRice@diplomat.is
Abigail Bearman , Diplomat
810.768.9563 | firstname.lastname@example.org